Alpha DNA Investment Management’s iShares MSCI EAFE ETF EFA Stock Holding History
Bought
Maintained
Sold
Other funds holding EFA
Alpha DNA Investment Management's EFA Position: Q2 2023 in Review
Alpha DNA Investment Management sold out of iShares MSCI EAFE ETF (EFA) in Q2 2023, closing a stake of 3,070 shares — an estimated $220K sold.
Alpha DNA Investment Management first reported a position in EFA in Q4 2020 and held it in 3 quarters. The position peaked at $220K in Q1 2023. 1,778 funds tracked by Wall St. Rank hold EFA as of Q2 2023.
- Alpha DNA Investment Management reported no remaining iShares MSCI EAFE ETF position as of Q2 2023 after selling out during the quarter.
- Alpha DNA Investment Management sold 3,070 iShares MSCI EAFE ETF shares in Q2 2023, an estimated $220K.
- Alpha DNA Investment Management first reported a position in iShares MSCI EAFE ETF in Q4 2020 and held it in 3 quarters.
- Alpha DNA Investment Management's iShares MSCI EAFE ETF position peaked at $220K in Q1 2023.
- 1,778 funds tracked by Wall St. Rank held iShares MSCI EAFE ETF as of Q2 2023.
Based on Alpha DNA Investment Management's 13F filing for Q2 2023, filed 31 Jul 2023.